Stay updated on Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a new release of the page without altering study information.
    Difference
    0.1%
    Check dated 2026-06-27T02:49:55.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added recruitment status and new user guidance sections to the study details page to clarify enrollment and participation steps. Included minor formatting changes to a heading and updated the revision label from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T16:39:41.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, signaling a minor update to the page version.
    Difference
    0.1%
    Check dated 2026-06-05T13:11:26.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, indicating a minor maintenance update to the ClinicalTrials.gov entry; no study details or results were affected.
    Difference
    0.1%
    Check dated 2026-05-15T06:53:21.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page footer revision version was updated from v3.5.2 to v3.5.3, indicating a minor ClinicalTrials.gov site version change rather than a change to the study record itself.
    Difference
    0.1%
    Check dated 2026-04-24T06:14:16.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:36:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.